Alpine Immune Sciences, Inc.
PD-1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
Last updated:
Abstract:
Provided herein are immunomodulatory proteins comprising variant PD-1 polypeptides, nucleic acids encoding such proteins and engineered cells expressing such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
Status:
Application
Type:
Utility
Filling date:
14 Jun 2019
Issue date:
25 Nov 2021